Vectors Research Management, LLC Gilead Sciences, Inc. Transaction History

Vectors Research Management, LLC

$326 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $19,255 - $23,481	-269 Reduced 2.84%	9,189 $673,000
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $12,089 - $13,709	-165 Reduced 1.71%	9,458 $767,000
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $1,996 - $2,178	-27 Reduced 0.28%	9,623 $690,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $33,900 - $38,668	-446 Reduced 4.42%	9,650 $744,000
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $14,998 - $17,087	-194 Reduced 1.89%	10,096 $838,000
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $21,313 - $30,598	-342 Reduced 3.22%	10,290 $883,000
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $7,025 - $8,025	-118 Reduced 1.1%	10,632 $656,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $16,507 - $18,592	-286 Reduced 2.59%	10,750 $664,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $28,728 - $35,999	-496 Reduced 4.3%	11,036 $656,000
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $35,229 - $39,986	543 Added 4.94%	11,532 $837,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $21,660 - $23,369	320 Added 3.0%	10,989 $768,000
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $16,121 - $17,614	254 Added 2.44%	10,669 $734,000
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $545,640 - $622,575	9,094 Added 688.42%	10,415 $673,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $2,605 - $2,969	-46 Reduced 3.37%	1,321 $77,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $62,037 - $78,001	-999 Reduced 42.22%	1,367 $84,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $13,382 - $15,540	-185 Reduced 7.25%	2,366 $182,000
Q1 2019 Jul 15, 2019	SELL	$62.53 - $70.05 $6,253 - $7,005	-100 Reduced 3.77%	2,551 $166,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $9,504 - $12,403	157 Added 6.3%	2,651 $166,000
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $177,772 - $196,826	2,494 New	2,494 $178,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Account